144 related articles for article (PubMed ID: 12195086)
1. Interventional nuclear medicine in hepatocellular carcinoma and other tumours.
Buscombe JR
Nucl Med Commun; 2002 Sep; 23(9):837-41. PubMed ID: 12195086
[TBL] [Abstract][Full Text] [Related]
2. Preliminary experience in radionuclide therapy of hepatocellular carcinoma using hepatic intra-arterial radio-conjugates.
Keng GH; Sundram FX; Yu SW; Somanesan S; Premaraj J; Oon CJ; Kwok R; Htoo MM
Ann Acad Med Singap; 2002 May; 31(3):382-6. PubMed ID: 12061301
[TBL] [Abstract][Full Text] [Related]
3. 131I thyroid uptake in patients treated with 131I-Lipiodol for hepatocellular carcinoma.
Toubeau M; Touzery C; Berriolo-Riedinger A; Cochet A; Brunotte F; Bedenne L; Cercueil JP; Krause D
Eur J Nucl Med; 2001 May; 28(5):669-70. PubMed ID: 11383874
[No Abstract] [Full Text] [Related]
4. Treatment of unresectable hepatocellular carcinoma: targeted therapies using iodized oil.
Bhattacharya S; Dusheiko GM
Princess Takamatsu Symp; 1995; 25():253-64. PubMed ID: 8875631
[TBL] [Abstract][Full Text] [Related]
5. Limitations of hyperselective intraarterial injections for the treatment of hepatocellular carcinoma.
Raoul JL; Bretagne JF; Bourguet P; Duvauferrier R
Invest Radiol; 1996 May; 31(5):305-7. PubMed ID: 8724131
[TBL] [Abstract][Full Text] [Related]
6. Radionuclide therapy of hepatocellular carcinoma.
Keng GH; Sundram FX
Ann Acad Med Singap; 2003 Jul; 32(4):518-24. PubMed ID: 12968558
[TBL] [Abstract][Full Text] [Related]
7. Iodine-131-Lipiodol for hepatocellular carcinoma: the benefits of targeting.
Novell JR; Hilson AJ
J Nucl Med; 1994 Aug; 35(8):1318-20. PubMed ID: 8046486
[No Abstract] [Full Text] [Related]
8. Iodized oil in the treatment of hepatocellular carcinoma.
Bhattacharya S; Novell JR; Winslet MC; Hobbs KE
Br J Surg; 1994 Nov; 81(11):1563-71. PubMed ID: 7827876
[TBL] [Abstract][Full Text] [Related]
9. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.
Sumie S; Yamashita F; Ando E; Tanaka M; Yano Y; Fukumori K; Sata M
AJR Am J Roentgenol; 2003 Nov; 181(5):1327-34. PubMed ID: 14573429
[TBL] [Abstract][Full Text] [Related]
10. Superselective intra-arterial radiometabolic therapy with I-131 lipiodol in hepatocellular carcinoma.
Maini CL; Scelsa MG; Fiumara C; Tofani A; Sciuto R; Tipaldi L; D'Annibale M; Santoro E
Clin Nucl Med; 1996 Mar; 21(3):221-6. PubMed ID: 8846568
[TBL] [Abstract][Full Text] [Related]
11. [Selective internal radiotherapy (radioembolization) and radiation therapy for HCC--current status and perspectives].
Hilgard P; Müller S; Hamami M; Sauerwein WS; Haberkorn U; Gerken G; Antoch G
Z Gastroenterol; 2009 Jan; 47(1):37-54. PubMed ID: 19156591
[TBL] [Abstract][Full Text] [Related]
12. Intra-arterial iodine 131-labeled lipiodol as adjuvant therapy after curative liver resection for hepatocellular carcinoma: a phase 2 clinical study.
Partensky C; Sassolas G; Henry L; Paliard P; Maddern GJ
Arch Surg; 2000 Nov; 135(11):1298-300. PubMed ID: 11074884
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival.
Lau WY; Lai EC; Leung TW; Yu SC
Ann Surg; 2008 Jan; 247(1):43-8. PubMed ID: 18156922
[TBL] [Abstract][Full Text] [Related]
14. [Chemo-embolization of inoperable hepatocellular cancer. A surgical-radiologic therapy concept].
Pirschel J; Lauchart W
Helv Chir Acta; 1991 May; 57(6):889-93. PubMed ID: 1653775
[TBL] [Abstract][Full Text] [Related]
15. Hepatic intraarterial 131I iodized oil for treatment of hepatocellular carcinoma in patients with impeded portal venous flow.
de Baere T; Taourel P; Tubiana JM; Kuoch V; Ducreux M; Lumbroso J; Roche AJ
Radiology; 1999 Sep; 212(3):665-8. PubMed ID: 10478229
[TBL] [Abstract][Full Text] [Related]
16. New interventions for liver tumors.
Ramsey DE; Geschwind JF
Semin Roentgenol; 2002 Oct; 37(4):303-11. PubMed ID: 12455128
[No Abstract] [Full Text] [Related]
17. [Therapy of hepatocellular carcinoma].
Allgaier HP; Deibert P; Blum U; Spangenberg HC; Moser E; Blum HE
Schweiz Med Wochenschr; 1996 Nov; 126(46):1984-94. PubMed ID: 8984607
[TBL] [Abstract][Full Text] [Related]
18. Therapy of hepatocellular cancer with iodine-131-Lipiodol.
Risse JH; Menzel C; Grünwald F; Strunk H; Biersack HJ; Palmedo H
Rom J Gastroenterol; 2004 Jun; 13(2):119-24. PubMed ID: 15229776
[TBL] [Abstract][Full Text] [Related]
19. Hepatic resection with or without adjuvant iodine-131-lipiodol for hepatocellular carcinoma: a comparative analysis.
Chua TC; Saxena A; Chu F; Butler SP; Quinn RJ; Glenn D; Morris DL
Int J Clin Oncol; 2011 Apr; 16(2):125-32. PubMed ID: 21061140
[TBL] [Abstract][Full Text] [Related]
20. Nodular hepatocellular carcinoma--treatment with intraarterial injection of I-131 Lipiodol.
Yoo HS; Suh JH; Lee JT; Kim KW; Kim DI; Kim BS; Choi HJ; Lee KS
J Korean Med Sci; 1990 Jun; 5(2):75-83. PubMed ID: 2177607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
